
FDA Watch: New BD Collection System Uses Just Tiny Amounts of Blood
Whether the MiniDraw™ device dredges up memories of Theranos’ failed tech remains to be seen.
Whether the MiniDraw™ device dredges up memories of Theranos’ failed tech remains to be seen.
Congress is renewing its previous efforts to make Medicare reimbursement of pharmacy testing permanent—here’s what that could mean for labs.
Principal investigator discusses a new research initiative to create a low-cost, rapid HIV self-test.
The new guidelines address issues with false negatives and positives from POC testing for fertility and reproductive health.
By Leora Borgenicht bio
Before the healthcare industry can ambitiously transform to offer more accurate and personalized patient care, certain stepping stones must…